Mechanisms Involved in Platelet Hyperactivation and Platelet-endothelium Interrelationships in Diabetes Mellitus

Overview

Journal Curr Diab Rep

Publisher Current Science

Specialty Endocrinology

Date 2003 Mar 20

PMID 12643191

Citations 5

Authors

Mariella Trovati

Giovanni Anfossi

Affiliations

Soon will be listed here.

Abstract

This article discusses the recent findings about the mechanisms involved in platelet hyperactivation in diabetes mellitus. Particular attention is focused on the advances pertaining to 1) new features of platelet activation; 2) the role of calcium fluxes; 3) the role of glucose, insulin, and insulin resistance; 4) the role of nitric oxide; and 5) the role of endothelium.

Citing Articles

Mediation Effect of Platelet Traits on Associations of Central Obesity with Aging Biomarkers in Rural Adults of Henan, China.

Chen X, Li R, Hou X, Wang Y, Pan M, Kang N Nutrients. 2022; 14(17).

PMID: 36079858 PMC: 9460072. DOI: 10.3390/nu14173597.

Breaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticles.

Lannan K, Sahler J, Kim N, Spinelli S, Maggirwar S, Garraud O Front Immunol. 2015; 6:48.

PMID: 25762994 PMC: 4327621. DOI: 10.3389/fimmu.2015.00048.

The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance.

Russo I Scientifica (Cairo). 2013; 2012:525374.

PMID: 24278711 PMC: 3820496. DOI: 10.6064/2012/525374.

Suboptimal inhibition of platelet cyclooxygenase-1 by aspirin in metabolic syndrome.

Smith J, Haddad E, Taylor M, Oram D, Blakemore D, Chen Q Hypertension. 2012; 59(3):719-25.

PMID: 22311905 PMC: 3418792. DOI: 10.1161/HYPERTENSIONAHA.111.181404.

The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.

Spinelli S, OBrien J, Bancos S, Lehmann G, Springer D, Blumberg N PPAR Res. 2008; 2008:328172.

PMID: 18288284 PMC: 2233896. DOI: 10.1155/2008/328172.

References

Seghieri G, Di Simplicio P, Anichini R, Alviggi L, De Bellis A, Bennardini F . Platelet antioxidant enzymes in insulin-dependent diabetes mellitus. Clin Chim Acta. 2001; 309(1):19-23. DOI: 10.1016/s0009-8981(01)00494-6. View

Romano M, Pomilio M, Vigneri S, Falco A, Chiesa P, Chiarelli F . Endothelial perturbation in children and adolescents with type 1 diabetes: association with markers of the inflammatory reaction. Diabetes Care. 2001; 24(9):1674-8. DOI: 10.2337/diacare.24.9.1674. View

Loscalzo J . Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res. 2001; 88(8):756-62. DOI: 10.1161/hh0801.089861. View

Martina V, Bruno G, Zumpano E, Origlia C, Quaranta L, Pescarmona G . Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1. J Endocrinol Invest. 2001; 24(1):37-41. DOI: 10.1007/BF03343806. View

Assert R, Scherk G, Bumbure A, Pirags V, Schatz H, Pfeiffer A . Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro. Diabetologia. 2001; 44(2):188-95. DOI: 10.1007/s001250051598. View

Trovati M, Anfossi G . Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function. J Diabetes Complications. 2002; 16(1):35-40. DOI: 10.1016/s1056-8727(01)00196-9. View

Baron A . Insulin resistance and vascular function. J Diabetes Complications. 2002; 16(1):92-102. DOI: 10.1016/s1056-8727(01)00209-4. View

Anfossi G, Russo I, Massucco P, Mattiello L, Trovati M . Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. Thromb Haemost. 2002; 87(3):539-40. View

Aljada A, Ghanim H, Assian E, Dandona P . Tumor necrosis factor-alpha inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells. Metabolism. 2002; 51(4):487-91. DOI: 10.1053/meta.2002.31339. View

10.

Kaplar M, Kappelmayer J, Veszpremi A, Szabo K, Udvardy M . The possible association of in vivo leukocyte-platelet heterophilic aggregate formation and the development of diabetic angiopathy. Platelets. 2001; 12(7):419-22. DOI: 10.1080/09537100120078368. View

11.

Wang Z, Shi J, Han Y, Wang Y, Ruan C . Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease. Blood Coagul Fibrinolysis. 2001; 12(7):531-7. DOI: 10.1097/00001721-200110000-00004. View

12.

Mutus B, Rabini R, Staffolani R, Ricciotti R, Fumelli P, Moretti N . Homocysteine-induced inhibition of nitric oxide production in platelets: a study on healthy and diabetic subjects. Diabetologia. 2001; 44(8):979-82. DOI: 10.1007/s001250100581. View

13.

Carr M . Diabetes mellitus: a hypercoagulable state. J Diabetes Complications. 2001; 15(1):44-54. DOI: 10.1016/s1056-8727(00)00132-x. View

14.

Yngen M, Li N, Hjemdahl P, Wallen N . Insulin enhances platelet activation in vitro. Thromb Res. 2001; 104(2):85-91. DOI: 10.1016/s0049-3848(01)00348-6. View

15.

Srivastava K, Dash D . Changes in membrane microenvironment and signal transduction in platelets from NIDDM patients-a pilot study. Clin Chim Acta. 2002; 317(1-2):213-20. DOI: 10.1016/s0009-8981(01)00794-x. View

16.

Gupta S, Chough E, Daley J, Oates P, Tornheim K, Ruderman N . Hyperglycemia increases endothelial superoxide that impairs smooth muscle cell Na+-K+-ATPase activity. Am J Physiol Cell Physiol. 2002; 282(3):C560-6. DOI: 10.1152/ajpcell.00343.2001. View

17.

Wieclawska B, Rozalski M, Trojanowski Z, Watala C . Modulators of intraplatelet calcium concentration affect the binding of thrombospondin to blood platelets in healthy donors and patients with type 2 diabetes mellitus. Eur J Haematol. 2001; 66(6):396-403. DOI: 10.1034/j.1600-0609.2001.066006396.x. View

18.

Li Y, Woo V, Bose R . Platelet hyperactivity and abnormal Ca(2+) homeostasis in diabetes mellitus. Am J Physiol Heart Circ Physiol. 2001; 280(4):H1480-9. DOI: 10.1152/ajpheart.2001.280.4.H1480. View

19.

Schnyder B, Pittet M, Durand J, Schnyder-Candrian S . Rapid effects of glucose on the insulin signaling of endothelial NO generation and epithelial Na transport. Am J Physiol Endocrinol Metab. 2001; 282(1):E87-94. DOI: 10.1152/ajpendo.00050.2001. View

20.

Goligorsky M, Chen J, Brodsky S . Workshop: endothelial cell dysfunction leading to diabetic nephropathy : focus on nitric oxide. Hypertension. 2001; 37(2 Pt 2):744-8. DOI: 10.1161/01.hyp.37.2.744. View